Quick Links

Genome Québec

Medication against schizophrenia inhibits pancreatic cancer

A receptor for the dopamine neurotransmitter promotes growth and spread of pancreatic cancer -- and schizophrenia drugs, which block the function of this receptor, slowed tumor growth and metastatic spread in mice, according to researchers at McGill University and the German Cancer Research Center.

Published: 7Sep2016

Great performance of Québec researchers at last GAPP

McGill Newsroom

Génome Québec is happy to report that Québec has achieved excellent results in the 5th cycle of the Genomic Applications Partnership Program (GAPP).

Published: 12Jul2016